Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer

30 Mar 2016

Abstract excerpt

OBJECTIVE: We aimed to explore the potential application of circulating microRNA-451 (miR-451) in serum in predicting the resistance to neoadjuvant chemotherapy (NACT) in breast cancer (BC). METHODS: Eighty-two BC patients who underwent NACT were recruited in our study, including 41 NACT-sensitive patients (NACT-sensitive group) and 41 NACT-resistant patients (NACT-resistant group). Additionally, 60 healthy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Extracellular vesicles in disease
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27062696
DOI: 10.3233/cbm-160578

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancerPMID 27062696Read ↗

Identification and targeting of microRNAs modulating acquired chemotherapy resistance in Triple negative breast cancer (TNBC): A better strategy to combat chemoresistance.Semantic proximity Read ↗

Crosstalk between miRNAs and signaling pathways in the development of drug resistance in breast cancerSemantic proximity Read ↗

MiR-324-5P Functions as a Novel Serum Biomarker and Modulates Breast Cancer Malignant ActivitySemantic proximity Read ↗

Bioinformatic Analysis of Peripheral Blood miRNA of Breast Cancer Patients in Relation With Anthracycline CardiotoxicitySemantic proximity Read ↗

Dynamics of circulating micro RNA s as a novel indicator of clinical response to neoadjuvant chemotherapy in breast cancerSemantic proximity Read ↗

Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicitySemantic proximity Read ↗

miR-1275 Targets MDK/AKT Signaling to Inhibit Breast Cancer Chemoresistance by Lessening the Properties of Cancer Stem CellsSemantic proximity Read ↗

CircRNA_100876 promote proliferation and metastasis of breast cancer cells through adsorbing microRNA-361-3p in a sponge form.Semantic proximity Read ↗

MiR-200c Sensitizes Breast Cancer Cells to Carboplatin Treatment by Decreasing MDR1 ExpressionSemantic proximity Read ↗

Using Circulating MicroRNAs as Noninvasive Cancer Biomarkers in Breast Cancer is a Cutting-Edge Application of MicroRNA Profiling TechnologySemantic proximity Read ↗

Drug-resistant extracellular vesicles: a reliable biomarker for predicting therapeutic response in patients with triple-negative breast cancer receiving neoadjuvant chemotherapySemantic proximity Read ↗

Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7/Adr cells by Solexa deep-sequencing technology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.